Lead Product(s) : Epoprostenol Sodium
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Ohio State University
Deal Size : Inapplicable
Deal Type : Inapplicable
VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation
Details : Epoprostenol is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 30, 2020
Lead Product(s) : Epoprostenol Sodium
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Ohio State University
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
